Friday, July 15, 2016

Health - Startup Digest - July 15th - July 22nd

Startup Digest

Health

July 15, 2016

Startup Highlight: GliaLab

GliaLab is the brainchild of wunderkind 19 year old Abu Qadar. He's focusing on creating an AI that can detect breast cancer on scans between 93%-99% of the time. While AI for breast cancer diagnosis has been around academically for a few years, the fact that you have a 19 year old attacking the problem so successfully is very cool. He already has some partnerships under his built, and has higher hopes within health care, and beyond.

As always, if you come across news, announcements, videos, or podcasts that you think everyone else would benefit from, e-mail me at scott.munro@startupdigestmail.com or tweet @R_Scott_Munro.

Quote of the Week

"By working with the game maker to engineer member-specific engagement toward physical activity (fitness club incentives on steroids, pun intended) that relies on fractional payment, similar to online music sales for single tracks vs. albums, Niantic Labs can behave as a de facto wellness company without changing its business model while massively differentiating its revenue potential."

- Taqee Khaled

Health Startup Digest is curated by:
R. Scott Munro

R. Scott Munro - Utility Infielder @ DocMatter

Contact R. Scott Munro at scott.munro@startupdigestmail.com

Want the latest startup news and resources from Techstars?

Get the scoop on our newest accelerator companies and founders, find out when new program applications open, learn about our events, and much, much more! Sign up here!

​Pokémon Go & Digital Health

Taqee Khaled - Medium

The moment Pokemon Go started taking off in the way it did, people started getting excited about the health ramifications. Cardiogram actually did a study that showed the uptick in exercise that their users saw after the game was released. This article goes into a bit more detail about how insurers might pay Niantic (or similar companies) for this type of intervention, given the previously sedentary members that are walking 5-10 miles a day when they used to not walk at all.

Innovation for Medically Vulnerable Populations, Part 2: Foundation & Hypothesis Formation

Vanessa Mason, MPH // Erica Levine - Tincture

This is part two of the five part series on innovation for the medically vulnerable that Vanessa Mason and Erica Levine are putting together. This installment focuses more on the idea generation phase of innovation, and how we can begin to think through models of behavior change that take into account the environments and needs of these populations. Definitely a great read for entrepreneurs thinking about starting companies in the space.

The Paradox of Disclosure

Sunita Sah - NYT

A new wrinkle in the conflict of interest / pharmascold discussion: what if disclosing financial ties actually HURTS our ability to act in an unbiased fashion. That is exactly what the research of Sunita Sah found. This leaves us in quite a pickle, we know that even receiving lunch can sway doctors' opinions, and we know that financial disclosures may have the effect of making doctors more biased as well. What's left? Remove life sciences' influence all together? Not likely given the industry is also funding large amounts of innovation...

National Health Expenditure Projections, 2015–25: Economy, Prices, And Aging Expected To Shape Spending And Enrollment

Sean P. Keehan, John A. Poisal, Gigi A. Cuckler, Andrea M. Sisko, Sheila D. Smith, Andrew J. Madison, Devin A. Stone, Christian J. Wolfe and Joseph M. Lizonitz - Health Affairs

New data is out forecasting health care expenditure in the US through 2025. There is a lot to unpack here, so I'll let folks take a look themselves. High level, costs are still growing too fast (1.3% faster than GDP growth), but actually not as fast as they have been. The end result will be a health care system that accounts for around 20% of GDP by 2025, up from 17% today. 

Q&A: Why the World Health Organization Plans a Fair Pricing Model For Drugs

Ed Silverman - STAT

"Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals. Toward that end, the agency plans to convene governments, patient groups, and drug makers to fashion the notion into something realistic. The trick is to find the right balance between access to affordable medicines and enticing companies to develop new and improved medicines, while also ensuring lower-cost generics remain available. [STAT] spoke with Suzanne Hill, the WHO Director of Essential Medicines and Health Products, about how the agency hopes to get this done. This is an edited version of our conversation."

You are receiving this email because you believe that the best startup articles and videos are made by active members of the startup community.

Startup Digest, © 2009-2016 by Techstars Central LLC. All rights reserved. Startup Digest is a registered trademark of Techstars Central, LLC. Privacy Policy | Terms of Use.







This email was sent to startupdigest@joff3.com
why did I get this?    unsubscribe from this list    update subscription preferences
Techstars · 1050 Walnut St #202 · Boulder, CO 80302 · USA

No comments:

Post a Comment